PK Study of Xevinapant (Debio 1143) in Healthy East Asian Participants
Clinical trial NCT05519540 · COMPLETED
Trial details
- NCT number
- NCT05519540
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-26
- Primary completion
- 2023-04-21
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.